Your browser doesn't support javascript.
loading
Home administration of bortezomib in multiple myeloma is cost-effective and is preferred by patients compared with hospital administration: results of a prospective single-center study.
Lassalle, A; Thomaré, P; Fronteau, C; Mahé, B; Jubé, C; Blin, N; Voldoire, M; Dubruille, V; Tessoulin, B; Touzeau, C; Chauvin, C; Loirat, M; Lok, A; Bourcier, J; Lestang, E; Mocquet, R; Barbarot, V; Moreau, P.
Afiliação
  • Lassalle A; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Thomaré P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Fronteau C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Mahé B; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Jubé C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Blin N; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Voldoire M; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Dubruille V; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Tessoulin B; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Touzeau C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Chauvin C; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Loirat M; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Lok A; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Bourcier J; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Lestang E; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Mocquet R; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Barbarot V; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France.
  • Moreau P; Department of Hematology, University Hospital Hôtel-Dieu, Nantes, France philippe.moreau@chu-nantes.fr.
Ann Oncol ; 27(2): 314-8, 2016 Feb.
Article em En | MEDLINE | ID: mdl-26578729

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Satisfação do Paciente / Preferência do Paciente / Bortezomib / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Satisfação do Paciente / Preferência do Paciente / Bortezomib / Mieloma Múltiplo / Antineoplásicos Idioma: En Ano de publicação: 2016 Tipo de documento: Article